Skip to content

Trial evidence / Managed Futures Trend

11b181067d8da228

Hypothesis key 11b181067d8da228 Complete

First measurementNot recordedThis identity carries no first-measurement Sharpe. It is one of 4 such identities.

Forward epoch

Measured after the legacy epoch closed, under reservation ordinal 237. Register status DEVELOPMENT CLOSURE FINAL NOT ADMITTED. Final disposition KILL, not admitted: a development closure: the decision the study that ran this identity already made, imported and recorded, computing nothing.

Not ranked in the legacy distribution: that population is the retired epoch, and this identity belongs to the one after it.

Immutable first measurement

Hypothesis key
11b181067d8da228
Configuration hash
5eb0aa6336f81747
Research family
Managed Futures Trend
Packet status
COMPLETE_ACCOUNTING_FINAL_KILLED_NOT_ADMITTED
Observations
5,190
Annualized Sharpe
0.01480476
Skew
0.1226507
Kurtosis
14.4361

Evidence coverage

  1. Admission Or Kill Decision

    verified
    • Evidence6d9dd95c3a88917094d1365848ba0c65e344865f8abc14bc4c136f0426799f6d
    • Evidence46a3691c49e6485c2b29225a31a16a3bf6ddd606f111c016629881f44b414a7f
    • Evidence2a44565095dac9cdb4b5f4a83f0bfc4dbbd93b6f100c21f211ec420253b1b64e
    • Evidencea2202a67362f9511ba59a981e83d1eced03063aca1b7a15b6f10af4b8ecc0069
    • Evidencea22a65f92bcd48a9cbbcb52dd705edfadf67c0ba7ed26868303115dc238825d3
    • Evidence16948ebc39400dce9ed038fadde2211aa5c40f0b20b9d5131f60cf5d64944c92
    • Evidence70c08a522eb20999af1490e8691bfd5f897fd9ad89af30eb278dc40d8393483b
    • Evidencec6e979a0dbfdbf0a9d19fb37df515e0616d6e367254de2e843bf71fa81ff88e0
    • Evidencedfc0685344a0911fc777d434dde67ba5b3e97c1ef4dddac4aade08a99241b0b1
    • Evidence32b053add853a6df4a0ac758bd60105947a9256c015735889dc67673b3a435b1
    • Final Development Admission Closurea7e61df466df7326e81934552c88fe5a2a4778eb7e7e62627efdb61400605258
  2. Code Environment And Reproduction

    verified
    • Evidence6d9dd95c3a88917094d1365848ba0c65e344865f8abc14bc4c136f0426799f6d
    • Evidence46a3691c49e6485c2b29225a31a16a3bf6ddd606f111c016629881f44b414a7f
    • Evidence2a44565095dac9cdb4b5f4a83f0bfc4dbbd93b6f100c21f211ec420253b1b64e
    • Evidencea2202a67362f9511ba59a981e83d1eced03063aca1b7a15b6f10af4b8ecc0069
    • Evidencea22a65f92bcd48a9cbbcb52dd705edfadf67c0ba7ed26868303115dc238825d3
    • Evidence16948ebc39400dce9ed038fadde2211aa5c40f0b20b9d5131f60cf5d64944c92
    • Evidence70c08a522eb20999af1490e8691bfd5f897fd9ad89af30eb278dc40d8393483b
    • Evidencec6e979a0dbfdbf0a9d19fb37df515e0616d6e367254de2e843bf71fa81ff88e0
    • Evidencedfc0685344a0911fc777d434dde67ba5b3e97c1ef4dddac4aade08a99241b0b1
    • Evidence32b053add853a6df4a0ac758bd60105947a9256c015735889dc67673b3a435b1
  3. Economic Mechanism And Falsifiable Hypothesis

    verified
    • Evidence6d9dd95c3a88917094d1365848ba0c65e344865f8abc14bc4c136f0426799f6d
    • Evidence46a3691c49e6485c2b29225a31a16a3bf6ddd606f111c016629881f44b414a7f
    • Evidence2a44565095dac9cdb4b5f4a83f0bfc4dbbd93b6f100c21f211ec420253b1b64e
    • Evidencea2202a67362f9511ba59a981e83d1eced03063aca1b7a15b6f10af4b8ecc0069
    • Evidencea22a65f92bcd48a9cbbcb52dd705edfadf67c0ba7ed26868303115dc238825d3
    • Evidence16948ebc39400dce9ed038fadde2211aa5c40f0b20b9d5131f60cf5d64944c92
    • Evidence70c08a522eb20999af1490e8691bfd5f897fd9ad89af30eb278dc40d8393483b
    • Evidencec6e979a0dbfdbf0a9d19fb37df515e0616d6e367254de2e843bf71fa81ff88e0
    • Evidencedfc0685344a0911fc777d434dde67ba5b3e97c1ef4dddac4aade08a99241b0b1
    • Evidence32b053add853a6df4a0ac758bd60105947a9256c015735889dc67673b3a435b1
  4. Execution And Cost Model

    verified
    • Evidence6d9dd95c3a88917094d1365848ba0c65e344865f8abc14bc4c136f0426799f6d
    • Evidence46a3691c49e6485c2b29225a31a16a3bf6ddd606f111c016629881f44b414a7f
    • Evidence2a44565095dac9cdb4b5f4a83f0bfc4dbbd93b6f100c21f211ec420253b1b64e
    • Evidencea2202a67362f9511ba59a981e83d1eced03063aca1b7a15b6f10af4b8ecc0069
    • Evidencea22a65f92bcd48a9cbbcb52dd705edfadf67c0ba7ed26868303115dc238825d3
    • Evidence16948ebc39400dce9ed038fadde2211aa5c40f0b20b9d5131f60cf5d64944c92
    • Evidence70c08a522eb20999af1490e8691bfd5f897fd9ad89af30eb278dc40d8393483b
    • Evidencec6e979a0dbfdbf0a9d19fb37df515e0616d6e367254de2e843bf71fa81ff88e0
    • Evidencedfc0685344a0911fc777d434dde67ba5b3e97c1ef4dddac4aade08a99241b0b1
    • Evidence32b053add853a6df4a0ac758bd60105947a9256c015735889dc67673b3a435b1
  5. Family And Union Trial Accounting

    verified
    • Evidence6d9dd95c3a88917094d1365848ba0c65e344865f8abc14bc4c136f0426799f6d
    • Evidence46a3691c49e6485c2b29225a31a16a3bf6ddd606f111c016629881f44b414a7f
    • Evidence2a44565095dac9cdb4b5f4a83f0bfc4dbbd93b6f100c21f211ec420253b1b64e
    • Evidencea2202a67362f9511ba59a981e83d1eced03063aca1b7a15b6f10af4b8ecc0069
    • Evidencea22a65f92bcd48a9cbbcb52dd705edfadf67c0ba7ed26868303115dc238825d3
    • Evidence16948ebc39400dce9ed038fadde2211aa5c40f0b20b9d5131f60cf5d64944c92
    • Evidence70c08a522eb20999af1490e8691bfd5f897fd9ad89af30eb278dc40d8393483b
    • Evidencec6e979a0dbfdbf0a9d19fb37df515e0616d6e367254de2e843bf71fa81ff88e0
    • Evidencedfc0685344a0911fc777d434dde67ba5b3e97c1ef4dddac4aade08a99241b0b1
    • Evidence32b053add853a6df4a0ac758bd60105947a9256c015735889dc67673b3a435b1
  6. Identity And Authorship

    verified
    • Evidence6d9dd95c3a88917094d1365848ba0c65e344865f8abc14bc4c136f0426799f6d
    • Evidence46a3691c49e6485c2b29225a31a16a3bf6ddd606f111c016629881f44b414a7f
    • Evidence2a44565095dac9cdb4b5f4a83f0bfc4dbbd93b6f100c21f211ec420253b1b64e
    • Evidencea2202a67362f9511ba59a981e83d1eced03063aca1b7a15b6f10af4b8ecc0069
    • Evidencea22a65f92bcd48a9cbbcb52dd705edfadf67c0ba7ed26868303115dc238825d3
    • Evidence16948ebc39400dce9ed038fadde2211aa5c40f0b20b9d5131f60cf5d64944c92
    • Evidence70c08a522eb20999af1490e8691bfd5f897fd9ad89af30eb278dc40d8393483b
    • Evidencec6e979a0dbfdbf0a9d19fb37df515e0616d6e367254de2e843bf71fa81ff88e0
    • Evidencedfc0685344a0911fc777d434dde67ba5b3e97c1ef4dddac4aade08a99241b0b1
    • Evidence32b053add853a6df4a0ac758bd60105947a9256c015735889dc67673b3a435b1
  7. Literature And Overlap Decision

    verified
    • Evidence6d9dd95c3a88917094d1365848ba0c65e344865f8abc14bc4c136f0426799f6d
    • Evidence46a3691c49e6485c2b29225a31a16a3bf6ddd606f111c016629881f44b414a7f
    • Evidence2a44565095dac9cdb4b5f4a83f0bfc4dbbd93b6f100c21f211ec420253b1b64e
    • Evidencea2202a67362f9511ba59a981e83d1eced03063aca1b7a15b6f10af4b8ecc0069
    • Evidencea22a65f92bcd48a9cbbcb52dd705edfadf67c0ba7ed26868303115dc238825d3
    • Evidence16948ebc39400dce9ed038fadde2211aa5c40f0b20b9d5131f60cf5d64944c92
    • Evidence70c08a522eb20999af1490e8691bfd5f897fd9ad89af30eb278dc40d8393483b
    • Evidencec6e979a0dbfdbf0a9d19fb37df515e0616d6e367254de2e843bf71fa81ff88e0
    • Evidencedfc0685344a0911fc777d434dde67ba5b3e97c1ef4dddac4aade08a99241b0b1
    • Evidence32b053add853a6df4a0ac758bd60105947a9256c015735889dc67673b3a435b1
  8. Machine Readable Packet And Stable Public Paper

    verified
    • Evidence6d9dd95c3a88917094d1365848ba0c65e344865f8abc14bc4c136f0426799f6d
    • Evidence46a3691c49e6485c2b29225a31a16a3bf6ddd606f111c016629881f44b414a7f
    • Evidence2a44565095dac9cdb4b5f4a83f0bfc4dbbd93b6f100c21f211ec420253b1b64e
    • Evidencea2202a67362f9511ba59a981e83d1eced03063aca1b7a15b6f10af4b8ecc0069
    • Evidencea22a65f92bcd48a9cbbcb52dd705edfadf67c0ba7ed26868303115dc238825d3
    • Evidence16948ebc39400dce9ed038fadde2211aa5c40f0b20b9d5131f60cf5d64944c92
    • Evidence70c08a522eb20999af1490e8691bfd5f897fd9ad89af30eb278dc40d8393483b
    • Evidencec6e979a0dbfdbf0a9d19fb37df515e0616d6e367254de2e843bf71fa81ff88e0
    • Evidencedfc0685344a0911fc777d434dde67ba5b3e97c1ef4dddac4aade08a99241b0b1
    • Evidence32b053add853a6df4a0ac758bd60105947a9256c015735889dc67673b3a435b1
  9. Point In Time Data And Survivorship Controls

    verified
    • Evidence6d9dd95c3a88917094d1365848ba0c65e344865f8abc14bc4c136f0426799f6d
    • Evidence46a3691c49e6485c2b29225a31a16a3bf6ddd606f111c016629881f44b414a7f
    • Evidence2a44565095dac9cdb4b5f4a83f0bfc4dbbd93b6f100c21f211ec420253b1b64e
    • Evidencea2202a67362f9511ba59a981e83d1eced03063aca1b7a15b6f10af4b8ecc0069
    • Evidencea22a65f92bcd48a9cbbcb52dd705edfadf67c0ba7ed26868303115dc238825d3
    • Evidence16948ebc39400dce9ed038fadde2211aa5c40f0b20b9d5131f60cf5d64944c92
    • Evidence70c08a522eb20999af1490e8691bfd5f897fd9ad89af30eb278dc40d8393483b
    • Evidencec6e979a0dbfdbf0a9d19fb37df515e0616d6e367254de2e843bf71fa81ff88e0
    • Evidencedfc0685344a0911fc777d434dde67ba5b3e97c1ef4dddac4aade08a99241b0b1
    • Evidence32b053add853a6df4a0ac758bd60105947a9256c015735889dc67673b3a435b1
  10. Preregistration And Hashes

    verified
    • Evidence6d9dd95c3a88917094d1365848ba0c65e344865f8abc14bc4c136f0426799f6d
    • Evidence46a3691c49e6485c2b29225a31a16a3bf6ddd606f111c016629881f44b414a7f
    • Evidence2a44565095dac9cdb4b5f4a83f0bfc4dbbd93b6f100c21f211ec420253b1b64e
    • Evidencea2202a67362f9511ba59a981e83d1eced03063aca1b7a15b6f10af4b8ecc0069
    • Evidencea22a65f92bcd48a9cbbcb52dd705edfadf67c0ba7ed26868303115dc238825d3
    • Evidence16948ebc39400dce9ed038fadde2211aa5c40f0b20b9d5131f60cf5d64944c92
    • Evidence70c08a522eb20999af1490e8691bfd5f897fd9ad89af30eb278dc40d8393483b
    • Evidencec6e979a0dbfdbf0a9d19fb37df515e0616d6e367254de2e843bf71fa81ff88e0
    • Evidencedfc0685344a0911fc777d434dde67ba5b3e97c1ef4dddac4aade08a99241b0b1
    • Evidence32b053add853a6df4a0ac758bd60105947a9256c015735889dc67673b3a435b1
  11. Result Uncertainty Stress Capacity And Diversification

    verified
    • Evidence6d9dd95c3a88917094d1365848ba0c65e344865f8abc14bc4c136f0426799f6d
    • Evidence46a3691c49e6485c2b29225a31a16a3bf6ddd606f111c016629881f44b414a7f
    • Evidence2a44565095dac9cdb4b5f4a83f0bfc4dbbd93b6f100c21f211ec420253b1b64e
    • Evidencea2202a67362f9511ba59a981e83d1eced03063aca1b7a15b6f10af4b8ecc0069
    • Evidencea22a65f92bcd48a9cbbcb52dd705edfadf67c0ba7ed26868303115dc238825d3
    • Evidence16948ebc39400dce9ed038fadde2211aa5c40f0b20b9d5131f60cf5d64944c92
    • Evidence70c08a522eb20999af1490e8691bfd5f897fd9ad89af30eb278dc40d8393483b
    • Evidencec6e979a0dbfdbf0a9d19fb37df515e0616d6e367254de2e843bf71fa81ff88e0
    • Evidencedfc0685344a0911fc777d434dde67ba5b3e97c1ef4dddac4aade08a99241b0b1
    • Evidence32b053add853a6df4a0ac758bd60105947a9256c015735889dc67673b3a435b1

Completion assessment

COMPLETE_ACCOUNTING_FINAL_KILLED_NOT_ADMITTED

Frozen configuration

Allocator
trend
Alpha Names
mf_trend_63, mf_trend_126, mf_trend_252
Cov Halflife Days
Not reported
Cov Min Periods
240
Cov Window Bars
720
End
1,787,529,600,000
Evaluation Policy
continuous_single_book_v1
Execution Cost Scenario
Nested object preserved in the machine-readable packet
History Start
1,041,379,200,000
Initial Cash
100,000
Instrument Ids
List preserved in the machine-readable packet
Metric Basis
xnys_252_sessions_elapsed_cagr_v1
No Trade Band
0.001
Rebalance Bars
10
Start
1,136,246,400,000
Trend Ic History Anchor
1,073,001,600,000
Trend Label Availability
exit_session_close_v1

Verify the packet

Download the machine-readable packet · All trials

Packet content hash sha256:6aebe85b5d7772ee338bc4c9ea8cadc0b20e6b7083e0b12b7addc10f0007bd78